Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.
from The Medical News https://ift.tt/3jw9PDD
from The Medical News https://ift.tt/3jw9PDD
Comments
Post a Comment